Advocating for rituximab as first-line treatment for NMOSD-AQP4 patients in France: Cost and efficacy considerations
-
Published:2024-07
Issue:
Volume:
Page:
-
ISSN:0035-3787
-
Container-title:Revue Neurologique
-
language:en
-
Short-container-title:Revue Neurologique
Author:
Deschamps RomainORCID,
Papeix Caroline,
Ayrignac XavierORCID,
Bourre BertrandORCID,
Ciron JonathanORCID,
Cohen MikaelORCID,
Collongues NicolasORCID,
Deiva Kumaran,
Durand Dubief Françoise,
Laplaud David-Axel,
Maillart Elisabeth,
Michel LaureORCID,
Pique JulieORCID,
Ruet Aurélie,
Thouvenot Eric,
Zéphir HélèneORCID,
Marignier Romain,
Audoin Bertrand